Vascular anomalies: Difference between revisions
Hannan Javed (talk | contribs) |
Hannan Javed (talk | contribs) |
||
(13 intermediate revisions by 2 users not shown) | |||
Line 18: | Line 18: | ||
! colspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" + |Vascular Malformations | ! colspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" + |Vascular Malformations | ||
|- | |- | ||
! style="background:#7d7d7d; color: #FFFFFF;" align="center" + | | ! style="background:#7d7d7d; color: #FFFFFF;" align="center" + |Simple vascular malformation | ||
! style="background:#7d7d7d; color: #FFFFFF;" align="center" + | | ! style="background:#7d7d7d; color: #FFFFFF;" align="center" + |Combined vascular malformation* | ||
! style="background:#7d7d7d; color: #FFFFFF;" align="center" + |Vascular malformation of major named vessels | ! style="background:#7d7d7d; color: #FFFFFF;" align="center" + |Vascular malformation of major named vessels | ||
! style="background:#7d7d7d; color: #FFFFFF;" align="center" + | | ! style="background:#7d7d7d; color: #FFFFFF;" align="center" + |Vascular malformation associated with other anomalies | ||
|- | |- | ||
| style="background:#F5F5F5;" + | | | style="background:#F5F5F5;" + | | ||
Line 50: | Line 50: | ||
<sup>**</sup> High flow lesions | <sup>**</sup> High flow lesions | ||
|- | |- | ||
| colspan=" | | colspan="5" style="background:#7d7d7d; color: #FFFFFF;" + |<small>'''Adapted from International Society for the Study of Vascular Anomalies'''<ref name="urlClassification | International Society for the Study of Vascular Anomalies">{{cite web |url=http://www.issva.org/classification |title=Classification | International Society for the Study of Vascular Anomalies |format= |work= |accessdate=}}</ref></small> | ||
|} | |} | ||
===[[Classification of Vascular Tumors]]=== | ===[[Classification of Vascular Tumors]]=== | ||
{{Family tree/start}} | {{Family tree/start}} | ||
Line 96: | Line 95: | ||
<sup>*</sup>[[congenital hemangioma]] (rapidly involuting type) and [[tufted angioma]] may be associated with thrombocytopenia and/or consumptive coagulopathy in some cases. Many experts consider [[tufted angioma]] and [[kaposiform hemangioendothelioma]] to be part of a spectrum rather than distinct entities | <sup>*</sup>[[congenital hemangioma]] (rapidly involuting type) and [[tufted angioma]] may be associated with thrombocytopenia and/or consumptive coagulopathy in some cases. Many experts consider [[tufted angioma]] and [[kaposiform hemangioendothelioma]] to be part of a spectrum rather than distinct entities<br> | ||
'''Adapted from International Society for the Study of Vascular Anomalies'''<ref name="urlClassification | International Society for the Study of Vascular Anomalies">{{cite web |url=http://www.issva.org/classification |title=Classification | International Society for the Study of Vascular Anomalies |format= |work= |accessdate=}}</ref></small> | '''Adapted from International Society for the Study of Vascular Anomalies'''<ref name="urlClassification | International Society for the Study of Vascular Anomalies">{{cite web |url=http://www.issva.org/classification |title=Classification | International Society for the Study of Vascular Anomalies |format= |work= |accessdate=}}</ref></small> | ||
Line 117: | Line 116: | ||
</table>|I03=<br>(also known as "channel type" or "truncal" vascular malformations)<br><table> | </table>|I03=<br>(also known as "channel type" or "truncal" vascular malformations)<br><table> | ||
<tr><td>'''Affect'''</td></tr> | <tr><td>'''Affect'''</td></tr> | ||
<tr><td>• Lymphatics<td></tr> | <tr><td>• [[Lymphatics]]<td></tr> | ||
<tr><td>• Veins</tr> | <tr><td>• [[Veins]]</tr> | ||
<tr><td>• Arteries</tr> | <tr><td>• [[Arteries]]</tr> | ||
<tr><td>'''Anomalies of'''</td></tr> | <tr><td>'''Anomalies of'''</td></tr> | ||
<tr><td>• Origin<td></tr> | <tr><td>• Origin<td></tr> | ||
Line 182: | Line 181: | ||
{{Family tree | | | | | | | | | |`| F08 | | | | | | | | |F08=Others|}} | {{Family tree | | | | | | | | | |`| F08 | | | | | | | | |F08=Others|}} | ||
{{Family tree/end}} | {{Family tree/end}} | ||
'''Abbreviations:''' CM:capillary malformation; VM:venous malformation; CVM:capillary venous malformation; LM:lymphatic malformation; CLM:capillary lymphatic malformation; AVM:arteriovenous malformation; CAVM:capillary arteriovenous malformation; LVM:lymphatic venous malformation; CLVM:capillary lymphatic venous malformation; CVAVM:capillary venous arteriovenous malformation; CLVAVM:capillary lymphatic venous arteriovenous malformation; AVF:arteriovenous fistula; CLOVES:congenital lipomatous overgrowth, vascular malformations, epidermal nevi, skeletal/scoliosis and spinal abnormalities; M-CM:macrocephaly-capillary malformation; MCAP:megalencephaly-capillary malformation-polymicrogyria; MICCAP:microcephaly-capillary malformation; CNS:central nervous system; DCMO:diffuse capillary malformation with overgrowth; CM-AVM:capillary malformation-arteriovenous malformation; CMTC:cutis marmorata telangiectatica congenita; HHT:hereditary hemorrhagic telangiectasia; GLA:generalized lymphatic anomaly; KLA:kaposiform lymphangiomatosis; VMCM:venous malformation cutaneo mucosal; GVM:glomuvenous malformation; CCM:cerebral cavernous malformation. | <small>'''Abbreviations:''' CM:capillary malformation; VM:venous malformation; CVM:capillary venous malformation; LM:lymphatic malformation; CLM:capillary lymphatic malformation; AVM:arteriovenous malformation; CAVM:capillary arteriovenous malformation; LVM:lymphatic venous malformation; CLVM:capillary lymphatic venous malformation; CVAVM:capillary venous arteriovenous malformation; CLVAVM:capillary lymphatic venous arteriovenous malformation; AVF:arteriovenous fistula; CLOVES:congenital lipomatous overgrowth, vascular malformations, epidermal nevi, skeletal/scoliosis and spinal abnormalities; M-CM:macrocephaly-capillary malformation; MCAP:megalencephaly-capillary malformation-polymicrogyria; MICCAP:microcephaly-capillary malformation; CNS:central nervous system; DCMO:diffuse capillary malformation with overgrowth; CM-AVM:capillary malformation-arteriovenous malformation; CMTC:cutis marmorata telangiectatica congenita; HHT:hereditary hemorrhagic telangiectasia; GLA:generalized lymphatic anomaly; KLA:kaposiform lymphangiomatosis; VMCM:venous malformation cutaneo mucosal; GVM:glomuvenous malformation; CCM:cerebral cavernous malformation.</small> | ||
'''Adapted from International Society for the Study of Vascular Anomalies'''<ref name="urlClassification | International Society for the Study of Vascular Anomalies">{{cite web |url=http://www.issva.org/classification |title=Classification | International Society for the Study of Vascular Anomalies |format= |work= |accessdate=}}</ref></small> | '''Adapted from International Society for the Study of Vascular Anomalies'''<ref name="urlClassification | International Society for the Study of Vascular Anomalies">{{cite web |url=http://www.issva.org/classification |title=Classification | International Society for the Study of Vascular Anomalies |format= |work= |accessdate=}}</ref></small> | ||
Line 209: | Line 208: | ||
| colspan="2" style="background:#7d7d7d; color: #FFFFFF;" + |<small>'''Adapted from International Society for the Study of Vascular Anomalies'''<ref name="urlClassification | International Society for the Study of Vascular Anomalies">{{cite web |url=http://www.issva.org/classification |title=Classification | International Society for the Study of Vascular Anomalies |format= |work= |accessdate=}}</ref></small> | | colspan="2" style="background:#7d7d7d; color: #FFFFFF;" + |<small>'''Adapted from International Society for the Study of Vascular Anomalies'''<ref name="urlClassification | International Society for the Study of Vascular Anomalies">{{cite web |url=http://www.issva.org/classification |title=Classification | International Society for the Study of Vascular Anomalies |format= |work= |accessdate=}}</ref></small> | ||
|} | |} | ||
== Genetics in Vascular Anomalies == | <small>'''Abbreviations:''' VM:venous malformation; AVM:arteriovenous malformation; CAVM:capillary arteriovenous malformation; MLT:Multifocal lymphangioendotheliomatosis with thrombocytopenia; CAT:cutaneovisceral angiomatosis with thrombocytopenia; PHOST:PTEN hamartoma of soft tissue; FAVA:Fibro adipose vascular anomaly; AST:angiomatosis of soft tissue.</small> | ||
==Genetics in Vascular Anomalies== | |||
{| class="wikitable" | {| class="wikitable" | ||
! colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Causal genes of vascular anomalies | ! colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Causal genes of vascular anomalies | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |ACVRL1 | | style="background:#DCDCDC;" align="center" + |ACVRL1 | ||
|Telangiectasia, AVM and AVF of | |[[Telangiectasia]], [[AVM]] and [[AVF]] of [[HHT]]2 | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |AKT1 | | style="background:#DCDCDC;" align="center" + |AKT1 | ||
|Proteus syndrome | |[[Proteus syndrome]] | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |BRAF | | style="background:#DCDCDC;" align="center" + |BRAF | ||
|Pyogenic granuloma PG | |[[Pyogenic granuloma]] PG | ||
|- | |- | ||
| style="background:#DCDCDC" align="center" + |CAMTA1 | | style="background:#DCDCDC" align="center" + |CAMTA1 | ||
|Epithelioid hemangioendothelioma EHE | |[[Epithelioid hemangioendothelioma]] EHE | ||
|- | |- | ||
| style="background:#DCDCDC" align="center" + |CCBE1 | | style="background:#DCDCDC" align="center" + |CCBE1 | ||
|Primary generalized lymphatic anomaly (Hennekam lymphangiectasia-lymphedema syndrome) | |[[Primary generalized lymphatic anomaly]] (Hennekam lymphangiectasia-lymphedema syndrome) | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |ELMO2 | | style="background:#DCDCDC;" align="center" + |ELMO2 | ||
|Familial intraosseous vascular malformation VMOS | |[[Familial intraosseous vascular malformation]] [[VMOS]] | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |ENG | | style="background:#DCDCDC;" align="center" + |ENG | ||
|Telangiectasia, AVM and AVF of | |[[Telangiectasia]], [[AVM]] and [[AVF]] of [[HHT]]1 | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |EPHB4 | | style="background:#DCDCDC;" align="center" + |EPHB4 | ||
Line 241: | Line 240: | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |FLT4 | | style="background:#DCDCDC;" align="center" + |FLT4 | ||
|Nonne-Milroy syndrome (gene also named VEGFR3) | |[[Nonne-Milroy syndrome]] (gene also named VEGFR3) | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |FOS | | style="background:#DCDCDC;" align="center" + |FOS | ||
|Epithelioid hemangioma EH | |[[Epithelioid hemangioma]] EH | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |FOSB | | style="background:#DCDCDC;" align="center" + |FOSB | ||
|Pseudomyogenic hemangioendothelioma | |[[Pseudomyogenic hemangioendothelioma]] | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |FOXC2 | | style="background:#DCDCDC;" align="center" + |FOXC2 | ||
|Lymphedema-distichiasis | |[[Lymphedema-distichiasis]] | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |GATA2 | | style="background:#DCDCDC;" align="center" + |GATA2 | ||
|Primary lymphedema with myelodysplasia | |[[Primary lymphedema with myelodysplasia]] | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |GJC2 | | style="background:#DCDCDC;" align="center" + |GJC2 | ||
|Primary hereditary lymphedema | |[[Primary hereditary lymphedema]] | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |Glomulin | | style="background:#DCDCDC;" align="center" + |Glomulin | ||
|Glomuvenous malformation | |[[Glomuvenous malformation]] | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |GNA11 | | style="background:#DCDCDC;" align="center" + |GNA11 | ||
|Congenital hemangioma CH | |[[Congenital hemangioma]] CH | ||
CM with bone and/or soft tissue hyperplasia | CM with bone and/or soft tissue hyperplasia | ||
Diffuse CM with overgrowth DCMO | [[Diffuse CM with overgrowth]] [[DCMO]] | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |GNA14 | | style="background:#DCDCDC;" align="center" + |GNA14 | ||
|Tufted angioma TA | |[[Tufted angioma]] TA | ||
Pyogenic granuloma PG | [[Pyogenic granuloma]] PG | ||
Kaposiform hemangioendothelioma KHE | [[Kaposiform hemangioendothelioma]] KHE | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |GNAQ | | style="background:#DCDCDC;" align="center" + |GNAQ | ||
|Congenital hemangioma CH | |[[Congenital hemangioma]] CH | ||
CM "Port-wine" stain, nonsyndromic CM | CM [["Port-wine" stain]], [[nonsyndromic CM]] | ||
CM of Sturge-Weber syndrome | CM of [[Sturge-Weber syndrome]] | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |IDH1 | | style="background:#DCDCDC;" align="center" + |IDH1 | ||
|Maffucci syndrome | |[[Maffucci syndrome]] | ||
Spindle-cell hemangioma | [[Spindle-cell hemangioma]] | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |IDH2 | | style="background:#DCDCDC;" align="center" + |IDH2 | ||
|Maffucci syndrome | |[[Maffucci syndrome]] | ||
Spindle-cell hemangioma | [[Spindle-cell hemangioma]] | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |KIF11 | | style="background:#DCDCDC;" align="center" + |KIF11 | ||
Line 291: | Line 290: | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |KRIT1 | | style="background:#DCDCDC;" align="center" + |KRIT1 | ||
|Cerebral cavernous malformation | |[[Cerebral cavernous malformation]] [[CCM]]1 | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |Malcavernin | | style="background:#DCDCDC;" align="center" + |Malcavernin | ||
|Cerebral cavernous malformation | |[[Cerebral cavernous malformation]] [[CCM]]2 | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |MAP2K1 | | style="background:#DCDCDC;" align="center" + |MAP2K1 | ||
|Arteriovenous malformation AVM (sporadic) | |[[Arteriovenous malformation]] AVM (sporadic) | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |MAP2K1 | | style="background:#DCDCDC;" align="center" + |MAP2K1 | ||
|Ateriovenous fistula AVF (sporadic) | |[[Ateriovenous fistula]] [[AVF]] (sporadic) | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |MAP3K3 | | style="background:#DCDCDC;" align="center" + |MAP3K3 | ||
|Verrucous venous malformation (somatic) | |[[Verrucous venous malformation]] (somatic) | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |MYC | | style="background:#DCDCDC;" align="center" + |MYC | ||
|Post radiation angiosarcoma | |Post radiation [[angiosarcoma]] | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |NPM11 | | style="background:#DCDCDC;" align="center" + |NPM11 | ||
|Maffucci syndrome | |[[Maffucci syndrome]] | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |PDCD10 | | style="background:#DCDCDC;" align="center" + |PDCD10 | ||
|Cerebral cavernous malformation | |[[Cerebral cavernous malformation]] [[CCM]]3 | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |PIK3CA | | style="background:#DCDCDC;" align="center" + |PIK3CA | ||
|Common (cystic) LM (somatic)* | |[[Common (cystic) LM]] (somatic)* | ||
Common VM (somatic)* | [[Common VM]] (somatic)* | ||
Klippel-Trenaunay syndrome* | [[Klippel-Trenaunay syndrome]]* | ||
Megalencephaly-capillary malformation-polymicrogyria (MCAP)* | Megalencephaly-capillary malformation-polymicrogyria (MCAP)* | ||
CLOVES syndrome* | [[CLOVES syndrome]]* | ||
CLAPO syndrome* | [[CLAPO syndrome]]* | ||
Fibro adipose vascular anomaly FAVA | [[Fibro adipose vascular anomaly]] [[FAVA]] | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |PTEN | | style="background:#DCDCDC;" align="center" + |PTEN | ||
|Bannayan-Riley-Ruvalcaba syndrome | |[[Bannayan-Riley-Ruvalcaba syndrome]] | ||
PTEN (type) Hamartoma of soft tissue / "angiomatosis" of soft tissue | PTEN (type) Hamartoma of soft tissue / [["angiomatosis" of soft tissue]] | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |PTPN14 | | style="background:#DCDCDC;" align="center" + |PTPN14 | ||
|Lymphedema-choanal atresia | |[[Lymphedema-choanal atresia]] | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |RASA1 | | style="background:#DCDCDC;" align="center" + |RASA1 | ||
|CM-AVM1 | |CM-AVM1 | ||
Parkes Weber syndrome | [[Parkes Weber syndrome]] | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |SMAD4 | | style="background:#DCDCDC;" align="center" + |SMAD4 | ||
|Telangiectasia, AVM and AVF of Juvenile polyposis hemorrhagic telangiectasia JPHT | |[[Telangiectasia]], [[AVM]] and [[AVF]] of [[Juvenile polyposis hemorrhagic telangiectasia]] JPHT | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |SOX18 | | style="background:#DCDCDC;" align="center" + |SOX18 | ||
|Hypotrichosis-lymphedema-telangiectasia | |[[Hypotrichosis-lymphedema-telangiectasia]] | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |STAMBP | | style="background:#DCDCDC;" align="center" + |STAMBP | ||
Line 349: | Line 348: | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |TEK (TIE2) | | style="background:#DCDCDC;" align="center" + |TEK (TIE2) | ||
|Common VM (somatic) | |[[Common VM]] (somatic) | ||
Familial VM cutaneo-mucosal VMCM | [[Familial VM cutaneo-mucosal]] [[VMCM]] | ||
Blue rubber bleb nevus (Bean) syndrome (somatic) | [[Blue rubber bleb nevus (Bean) syndrome]] (somatic) | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |TFE3 | | style="background:#DCDCDC;" align="center" + |TFE3 | ||
|Epithelioid hemangioendothelioma EHE | |[[Epithelioid hemangioendothelioma]] EHE | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |VEGFC | | style="background:#DCDCDC;" align="center" + |VEGFC | ||
|Primary hereditary lymphedema | |[[Primary hereditary lymphedema]] | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |VEGFR3 | | style="background:#DCDCDC;" align="center" + |VEGFR3 | ||
|Nonne-Milroy syndrome (gene also named FLT4) | |[[Nonne-Milroy syndrome]] (gene also named FLT4) | ||
|- | |- | ||
| colspan="2" style="background:#DCDCDC;" + |<sup>*</sup>Some of these lesions, associated with overgrowth, belong to the PIK3CA related overgrowth spectrum PROS | | colspan="2" style="background:#DCDCDC;" + |<sup>*</sup>Some of these lesions, associated with overgrowth, belong to the PIK3CA related overgrowth spectrum PROS | ||
Line 374: | Line 373: | ||
!style="background:#4479BA; color: #FFFFFF;" align="center" + |Hematological disorders | !style="background:#4479BA; color: #FFFFFF;" align="center" + |Hematological disorders | ||
|- | |- | ||
|Tufted angioma | |[[Tufted angioma]] | ||
Kaposiform hemangioendothelioma | [[Kaposiform hemangioendothelioma]] | ||
|Profound and sustained thrombocytopenia with profound | |Profound and sustained thrombocytopenia with profound | ||
hypofibrinogenemia, consumptive coagulopathy and | hypofibrinogenemia, consumptive coagulopathy and | ||
elevated D-dimer (Kasabach-Merritt phenomenon | elevated D-dimer (Kasabach-Merritt phenomenon) | ||
|- | |- | ||
|Rapidly involuting congenital | |[[Rapidly involuting congenital hemangioma]] | ||
hemangioma | |||
|Transient mild/moderate thrombocytopenia, +/- | |Transient mild/moderate thrombocytopenia, +/- | ||
consumptive coagulopathy and elevated D-dimer | consumptive coagulopathy and elevated D-dimer | ||
|- | |- | ||
|Venous malformations / | |[[Venous malformations]] / | ||
Lymphatic-venous malformations | Lymphatic-venous malformations | ||
|Chronic localized intravascular coagulopathy with | |Chronic localized intravascular coagulopathy with | ||
Line 395: | Line 393: | ||
after trauma or operation) | after trauma or operation) | ||
|- | |- | ||
|Lymphatic malformations | |[[Lymphatic malformations]] | ||
|Chronic localized intravascular coagulopathy with | |Chronic localized intravascular coagulopathy with | ||
elevated D-dimer and +/- mild to moderate | elevated D-dimer and +/- mild to moderate | ||
Line 401: | Line 399: | ||
thrombocytopenia | thrombocytopenia | ||
(consider Kaposiform lymphangiomatosis) | (consider [[Kaposiform lymphangiomatosis]]) | ||
(may progress to DIC after trauma or operation) | (may progress to DIC after trauma or operation) | ||
|- | |- | ||
|Multifocal lymphangioendotheliomatosis | |[[Multifocal lymphangioendotheliomatosis with thrombocytopenia]] / | ||
with thrombocytopenia / | |||
thrombocytopenia | [[Cutaneovisceral angiomatosis with thrombocytopenia]] | ||
|Sustained, fluctuating, moderate to profound | |Sustained, fluctuating, moderate to profound | ||
thrombocytopenia with gastrointestinal tract bleeding or | thrombocytopenia with gastrointestinal tract bleeding or | ||
Line 416: | Line 411: | ||
pulmonary hemorrhage | pulmonary hemorrhage | ||
|- | |- | ||
|Kaposiform lymphangiomatosis | |[[Kaposiform lymphangiomatosis]] | ||
|Mild/moderate thrombocytopenia, +/- | |Mild/moderate thrombocytopenia, +/- | ||
hypofibrinogenemia, and D-dimer elevation | hypofibrinogenemia, and D-dimer elevation |
Latest revision as of 15:32, 23 October 2018
For information on vascular tumors, click here.
For information on vascular malformations, click here.
For information on provisionally unclassified vascular anomalies, click here.
Vascular Anomalies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hannan Javed, M.D.[2], Anmol Pitliya, M.B.B.S. M.D.[3]
Overview
Vascular anomalies constitute a wide array of disorders ranging from benign lesions such as infantile hemangioma to aggressive malignant tumors such as angiosarcoma. Commonly used misnomers and confusing nomenclature has often presented difficulties for accurate diagnosis and appropriate management. International Society for the Study of Vascular Anomalies (ISSVA) has now classified vascular anomalies into vascular tumors and vascular malformations with an unclassified category for lesions that show clinical and histological characteristics unique from disorders classified in vascular tumors and vascular malformations.
Classification
Vascular Anomalies | ||||
---|---|---|---|---|
Vascular Tumors | Vascular Malformations | |||
Simple vascular malformation | Combined vascular malformation* | Vascular malformation of major named vessels | Vascular malformation associated with other anomalies | |
|
For details, Click here |
For details, Click here | For details, Click here | |
* Defined as two or more vascular malformations found in one lesion | ||||
Adapted from International Society for the Study of Vascular Anomalies[1] |
Classification of Vascular Tumors
Vascular tumors | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Benign | Locally aggressive or borderline | Malignant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Infantile hemangioma / Hemangioma of infancy | Kaposiform hemangioendothelioma | Angiosarcoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Congenital hemangioma | Retiform hemangioendothelioma | Epithelioid hemangioendothelioma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tufted angioma | Papillary intralymphatic angioendothelioma (PILA), Dabska tumor | Others | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Spindle-cell hemangioma | Composite hemangioendothelioma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Epithelioid hemangioma | Pseudomyogenic hemangioendothelioma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pyogenic granuloma (also known as lobular capillary hemangioma) | Polymorphous hemangioendothelioma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hemangioendothelioma not otherwise specified | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
'
| Kaposi sarcoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Others | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*congenital hemangioma (rapidly involuting type) and tufted angioma may be associated with thrombocytopenia and/or consumptive coagulopathy in some cases. Many experts consider tufted angioma and kaposiform hemangioendothelioma to be part of a spectrum rather than distinct entities
Adapted from International Society for the Study of Vascular Anomalies[1]
Classification of Vascular Malformations
Vascular malformations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Simple vascular malformations | Combined vascular malformations | Vascular malformations of major named vessels | Vascular malformations asscoiated with other anomalies | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (also known as "channel type" or "truncal" vascular malformations)
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Capillary malformations (CM) | Lymphatic malformations (LM) | Venous malformations (VM) | Arteriovenous malformation (AVM) | Arteriovenous fistula | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nevus simplex / salmon patch, “angel kiss”, “stork bite” |
| Common VM | Sporadic | Sporadic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Generalized lymphatic anomaly (GLA) Kaposiform lymphangiomatosis (KLA) | Familial VM cutaneo-mucosal (VMCM) | In HHT | In HHT | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LM in Gorham-Stout disease | Blue rubber bleb nevus (Bean) syndrome VM | In CM-AVM | In CM-AVM | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CM of CM-AVM | Channel type LM | Glomuvenous malformation (GVM) | Others | Others | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cutis marmorata telangiectatica congenita (CMTC) | “Acquired” progressive lymphatic anomaly (so called acquired progressive "lymphangioma") | Cerebral cavernous malformation (CCM) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Others | Primary lymphedema | Familial intraosseous vascular malformation (VMOS) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Others | Verrucous venous malformation (formerly verrucous hemangioma) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Others | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abbreviations: CM:capillary malformation; VM:venous malformation; CVM:capillary venous malformation; LM:lymphatic malformation; CLM:capillary lymphatic malformation; AVM:arteriovenous malformation; CAVM:capillary arteriovenous malformation; LVM:lymphatic venous malformation; CLVM:capillary lymphatic venous malformation; CVAVM:capillary venous arteriovenous malformation; CLVAVM:capillary lymphatic venous arteriovenous malformation; AVF:arteriovenous fistula; CLOVES:congenital lipomatous overgrowth, vascular malformations, epidermal nevi, skeletal/scoliosis and spinal abnormalities; M-CM:macrocephaly-capillary malformation; MCAP:megalencephaly-capillary malformation-polymicrogyria; MICCAP:microcephaly-capillary malformation; CNS:central nervous system; DCMO:diffuse capillary malformation with overgrowth; CM-AVM:capillary malformation-arteriovenous malformation; CMTC:cutis marmorata telangiectatica congenita; HHT:hereditary hemorrhagic telangiectasia; GLA:generalized lymphatic anomaly; KLA:kaposiform lymphangiomatosis; VMCM:venous malformation cutaneo mucosal; GVM:glomuvenous malformation; CCM:cerebral cavernous malformation.
Adapted from International Society for the Study of Vascular Anomalies[1]
Provisionally unclassified vascular anomalies
Provisionally unclassified vascular anomalies | |
---|---|
Intramuscular hemangioma * | |
Angiokeratoma | |
Sinusoidal hemangioma | |
Acral arteriovenous "tumour" | |
Multifocal lymphangioendotheliomatosis with thrombocytopenia / cutaneovisceral angiomatosis with thrombocytopenia (MLT/CAT) | |
PTEN (type) hamartoma of soft tissue / "angiomatosis" of soft tissue
(PHOST) | |
Fibro adipose vascular anomaly (FAVA) | |
* Distinct from infantile hemangioma, from intramuscular common VM, PHOST/AST, FAVA and AVM. Some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy. | |
Adapted from International Society for the Study of Vascular Anomalies[1] |
Abbreviations: VM:venous malformation; AVM:arteriovenous malformation; CAVM:capillary arteriovenous malformation; MLT:Multifocal lymphangioendotheliomatosis with thrombocytopenia; CAT:cutaneovisceral angiomatosis with thrombocytopenia; PHOST:PTEN hamartoma of soft tissue; FAVA:Fibro adipose vascular anomaly; AST:angiomatosis of soft tissue.
Genetics in Vascular Anomalies
Vascular anomalies possibly associated with platelet count / coagulation disorders
Anomalies | Hematological disorders |
---|---|
Tufted angioma | Profound and sustained thrombocytopenia with profound
hypofibrinogenemia, consumptive coagulopathy and elevated D-dimer (Kasabach-Merritt phenomenon) |
Rapidly involuting congenital hemangioma | Transient mild/moderate thrombocytopenia, +/-
consumptive coagulopathy and elevated D-dimer |
Venous malformations /
Lymphatic-venous malformations |
Chronic localized intravascular coagulopathy with
elevated D-dimer, +/- hypofibrinogenemia, and +/- moderate thrombocytopenia (may progress to DIC after trauma or operation) |
Lymphatic malformations | Chronic localized intravascular coagulopathy with
elevated D-dimer and +/- mild to moderate thrombocytopenia (consider Kaposiform lymphangiomatosis) (may progress to DIC after trauma or operation) |
Multifocal lymphangioendotheliomatosis with thrombocytopenia / | Sustained, fluctuating, moderate to profound
thrombocytopenia with gastrointestinal tract bleeding or pulmonary hemorrhage |
Kaposiform lymphangiomatosis | Mild/moderate thrombocytopenia, +/-
hypofibrinogenemia, and D-dimer elevation |
Adapted from International Society for the Study of Vascular Anomalies[1] |